1. Home
  2. SCPH vs ARL Comparison

SCPH vs ARL Comparison

Compare SCPH & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • ARL
  • Stock Information
  • Founded
  • SCPH 2013
  • ARL 1999
  • Country
  • SCPH United States
  • ARL United States
  • Employees
  • SCPH N/A
  • ARL 895
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • ARL Building operators
  • Sector
  • SCPH Health Care
  • ARL Real Estate
  • Exchange
  • SCPH Nasdaq
  • ARL Nasdaq
  • Market Cap
  • SCPH 173.6M
  • ARL 223.1M
  • IPO Year
  • SCPH 2017
  • ARL N/A
  • Fundamental
  • Price
  • SCPH $3.64
  • ARL $14.27
  • Analyst Decision
  • SCPH Strong Buy
  • ARL
  • Analyst Count
  • SCPH 3
  • ARL 0
  • Target Price
  • SCPH $14.00
  • ARL N/A
  • AVG Volume (30 Days)
  • SCPH 423.8K
  • ARL 4.3K
  • Earning Date
  • SCPH 05-14-2025
  • ARL 05-08-2025
  • Dividend Yield
  • SCPH N/A
  • ARL N/A
  • EPS Growth
  • SCPH N/A
  • ARL N/A
  • EPS
  • SCPH N/A
  • ARL N/A
  • Revenue
  • SCPH $41,982,000.00
  • ARL $48,234,000.00
  • Revenue This Year
  • SCPH $109.32
  • ARL N/A
  • Revenue Next Year
  • SCPH $76.95
  • ARL N/A
  • P/E Ratio
  • SCPH N/A
  • ARL N/A
  • Revenue Growth
  • SCPH 138.10
  • ARL N/A
  • 52 Week Low
  • SCPH $1.94
  • ARL $9.43
  • 52 Week High
  • SCPH $5.65
  • ARL $22.77
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 66.63
  • ARL 64.95
  • Support Level
  • SCPH $3.23
  • ARL $12.90
  • Resistance Level
  • SCPH $3.74
  • ARL $13.81
  • Average True Range (ATR)
  • SCPH 0.31
  • ARL 0.51
  • MACD
  • SCPH 0.08
  • ARL 0.07
  • Stochastic Oscillator
  • SCPH 93.81
  • ARL 74.46

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

Share on Social Networks: